| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.2M | +14.0% |
| Cost of Revenue | $1.3M | +1.0% |
| R&D Expense | $9.1M | -1.2% |
| SG&A Expense | $6.5M | +1.7% |
| Operating Income | -$8.5M | -285.2% |
| Pre-tax Income | -$7.3M | -332.6% |
| Income Tax | $59K | +20.4% |
| Net Income | -$7.3M | -323.8% |
| EPS (Basic) | -$0.35 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.0M | -14.9% |
| Accounts Receivable | $2.5M | -26.0% |
| Current Assets | $35.8M | -3.9% |
| Total Assets | $46.3M | -9.6% |
| Current Liabilities | $7.5M | +30.1% |
| Stockholders' Equity | $34.3M | -14.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.8M | +136.2% |
| Capital Expenditures | $16K | -97.8% |
| Investing Cash Flow | -$3.1M | +73.8% |
| Financing Cash Flow | -$426K | +64.0% |
| Free Cash Flow | $1.8M | +131.3% |
| -337.5% |
| EPS (Diluted) | -$0.35 | -337.5% |